Addressing Benefits, Risks and Consent in Next Generation Sequencing Studies.

Area of Science:

• Genomics
• Bioethics
• Bioinformatics

Background:

• Advances in DNA sequencing revolutionize genetic disorder diagnosis.
• Open access to genomic data must align with human subject research principles.
• Risks to patients in genomic studies are not fully understood.

Purpose of the Study:

• To address challenges in balancing open access genomic data sharing with patient privacy.
• To re-evaluate risks associated with genomic data sharing and establish new guidelines.
• To examine conflicts between federal regulations and data sharing requirements for NIH-funded studies.

Main Methods:

• Commentary on current ethical and regulatory frameworks for genomic data.
• Analysis of de-identification strategies and their limitations.
• Discussion of Big Data methodologies and re-identification risks.

Main Results:

• De-identified genomic data can be re-identified through various databases.
• DNA is an inherently identifying element, challenging traditional anonymity.
• Current data security standards may not adequately protect patient identity in the future.

Conclusions:

• Existing data security standards are insufficient to guarantee patient anonymity.
• New guidelines are needed for responsible genomic data sharing.
• Federally funded investigators face complex ethical and regulatory hurdles.